Z
Zhi-Sheng Jiang
Researcher at University of South China
Publications - 89
Citations - 2494
Zhi-Sheng Jiang is an academic researcher from University of South China. The author has contributed to research in topics: Inflammation & Endothelial stem cell. The author has an hindex of 25, co-authored 78 publications receiving 1850 citations. Previous affiliations of Zhi-Sheng Jiang include Sewanee: The University of the South & Libin Cardiovascular Institute of Alberta.
Papers
More filters
Journal ArticleDOI
New role of PCSK9 in atherosclerotic inflammation promotion involving the TLR4/NF-κB pathway
Zhi-Han Tang,Juan Peng,Zhong Ren,Jing Yang,Ting-Ting Li,Tao-Hua Li,Zuo Wang,Dangheng Wei,Lu-Shan Liu,Xi-Long Zheng,Zhi-Sheng Jiang +10 more
TL;DR: PCSK9 gene interference could suppress atherosclerosis directly through decreasing vascular inflammation and inhibiting the TLR4/NF-κB signaling pathway without affecting plasma cholesterol level in high-fat diet-fed apoE KO mice.
Journal ArticleDOI
PCSK9 siRNA suppresses the inflammatory response induced by oxLDL through inhibition of NF-κB activation in THP-1-derived macrophages
Zhi-Han Tang,Lu Jiang,Juan Peng,Zhong Ren,Dangheng Wei,Chunyang Wu,Li-Hong Pan,Zhi-Sheng Jiang,Lu-Shan Liu +8 more
TL;DR: It is suggested that PCSK9 may be used as a therapeutic target for the treatment of atherosclerosis since it suppresses oxLDL-induced IκB-α degradation and NF-κB nuclear translocation into THP-1-derived macrophages.
Journal ArticleDOI
PCSK9 siRNA inhibits HUVEC apoptosis induced by ox-LDL via Bcl/Bax–caspase9–caspase3 pathway
TL;DR: It is suggested that ox-LDL-induced HUVECs apoptosis could be inhibited by PCSK9 siRNA, in which Bcl/Bax–caspase9– caspase3 pathway maybe was involved through reducing the Bcl-2-Bax ratio and inhibited the activation of both caspases9 and 3.
Journal ArticleDOI
Hydrogen sulfide, the next potent preventive and therapeutic agent in aging and age-associated diseases.
TL;DR: An overview of the physiological functions and effects of H2S in aging and age-associated diseases, and the potential health and therapeutic benefits of H 2S are provided.
Journal ArticleDOI
Macrophage polarization in atherosclerosis.
Sai Yang,Hou-Qin Yuan,Ya-Meng Hao,Zhong Ren,Shun-Lin Qu,Lu-Shan Liu,Dang-Heng Wei,Zhi-Han Tang,Jifeng Zhang,Zhi-Sheng Jiang +9 more
TL;DR: A new perspective for Atherosclerosis therapy is provided by summarizing the relationship between macrophage polarization and atherosclerosis, as well as treatment targeting macrophages polarization.